The Musculoskeletal Tumor Registry (MsTR) is an essential part of the AAOS Registry Program, focusing on tracking data related to bone and soft tissue sarcomas. With data from over 1,900 procedures gathered as of August 2024, the MsTR helps clinicians and health systems monitor function, complications, and outcomes in patients treated for sarcomas.
By participating in the MsTR, healthcare providers can better understand the impact of their treatments and potentially improve patient outcomes. The Registry’s data can also support collaborative programs, quality certifications, and federal quality initiatives. By utilizing Epic SmartForms, surgeons can input exclusive data about their sarcoma patients at the point of care, enhancing data collection and standardization within the Registry.
Explore real-life case scenarios and learn about the transformative impact of data-driven healthcare through the MsTR. Visit the data submission page to understand the elements collected and access support resources. Stay updated on recent developments in the RegistryInsights platform and new opportunities to engage with AAOS Registry data.
For more information on how the Musculoskeletal Tumor Registry is paving the way to find a cure for sarcoma and improving orthopaedic practice, continue to follow updates and stories of sarcoma patients and surgeons.
Attribution:
This article was summarized and republished from the original source.
Please check the original article here: https://www.aaos.org/registries/musculoskeletal-tumor-registry/.